Dominion urges judge to compel Murdochs to testify live in Fox trial

Dominion urges judge to compel Murdochs to testify live in Fox trial


Rupert Murdoch, chairman of News Corp and co-chairman of 21st Century Fox, arrives at the Sun Valley Resort of the annual Allen & Company Sun Valley Conference, July 10, 2018 in Sun Valley, Idaho.

Drew Angerer | Getty Images

Dominion Voting Systems urged a Delaware judge to compel Fox Corp. Chairman Rupert Murdoch, and his son, Fox Corp. CEO Lachlan Murdoch, to appear live in court during the upcoming trial over its $1.6 billion defamation lawsuit against Fox and its networks.

In a letter to Judge Eric Davis on Wednesday, Dominion urged the judge to compel both Murdochs to appear live. It also requested in-person testimony from Paul Ryan, the Republican former speaker of the House and a Fox board member, and Viet Dinh, Fox’s chief legal and policy officer.

The letter comes days after the judge ruled that the lawsuit would go to trial in April.

Davis had rejected Fox’s arguments, but granted several of Dominion’s motions with the exception of its argument that Fox and its hosts acted with malice in broadcasting false claims about the 2020 presidential election between Donald Trump and Joe Biden.

The trial is scheduled to begin on April 17. Dominion and Fox have agreed that some of Fox’s top TV talent, including Tucker Carlson, Sean Hannity, Maria Bartiromo and Jeanine Pirro, as well as former host Lou Dobbs and Fox News CEO Suzanne Scott, will appear in court to give their testimonies live.

In earlier court papers Dominion did not included the Murdochs on its list for live testimony, although it had been earlier discussed in court.

Fox had opposed Murdoch, as well as the other Fox Corp. executives, giving their testimony live in court. They had also pointed to the elder Murdoch’s age, 92, as a reason for why he couldn’t appear live in court. The judge rejected that argument during last week’s hearing.

A Fox Corp. spokesperson pointed to what attorneys said earlier in court regarding the executives’ hours of testimony during their depositions and that they don’t hold the same relevance as witnesses since this case is about Fox News programming. Last week, a Fox News spokesperson called Dominion’s live witness list “another attempt to generate headlines and distract from the many shortcomings of its case. Ultimately, this case is about the First Amendment protections of the media’s absolute right to cover the news.”

Davis will preside over a hearing Wednesday to discuss the witness list.



Source

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push
Business

Sen. Warren blasts CFPB director for undermining Trump’s credit card affordability push

U.S. Senator Elizabeth Warren (D-MA) and Director of the United States Office of Management and Budget, Russell Vought. Kevin Mohatt | Kevin Lamarque | | Reuters Sen. Elizabeth Warren on Friday accused the acting head of the Consumer Financial Protection Bureau of undermining President Donald Trump’s stated push to make credit cards more affordable, according […]

Read More
Why a niche category of CRE lending is suddenly seeing record deals
Business

Why a niche category of CRE lending is suddenly seeing record deals

Wepro | Moment | Getty Images A version of this article first appeared in the CNBC Property Play newsletter with Diana Olick. Property Play covers new and evolving opportunities for the real estate investor, from individuals to venture capitalists, private equity funds, family offices, institutional investors and large public companies. Sign up to receive future editions, straight […]

Read More
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
Business

What obesity drugmakers see next in the market: More pills, easier access and drug combinations

A pharmacist displays a box of Wegovy pills at a pharmacy in Provo, Utah, Jan. 15, 2026. George Frey | Bloomberg | Getty Images The future of the booming obesity drug market won’t hinge on drugs that deliver greater weight loss alone.  Top executives from drugmakers big and small told CNBC that the next phase […]

Read More